close_game

close_game

Covovax Vaccine: All you need to know about Covid-19 booster dose

Published on Jan 09, 2023 03:04 PM IST

"Covovax will be approved as a booster in the next 10-15 days. It is actually the best booster because it works very well against Omicron, more than Covishield," said Chief Executive Officer Adar Poonawalla.

Share Via

Copy Link

1 / 9

Chief Executive Officer of Serum Institute of India, Adar Poonawalla, on Sunday said that its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus. (Representative Image (File Photo))

Published on Jan 09, 2023 03:04 PM IST

Chief Executive Officer of Serum Institute of India, Adar Poonawalla, on Sunday said that its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus. (Representative Image (File Photo))

2 / 9

Speaking to reporters at an event at the Bharati Vidyapeeth University on Sunday, Adar Poonawalla said, "Central Government has a lot of stock of Covisheild and also Covovax vaccine will get approval as a booster in the next 10 to 15 days." (Representative Image (Reuters))

Published on Jan 09, 2023 03:04 PM IST

Speaking to reporters at an event at the Bharati Vidyapeeth University on Sunday, Adar Poonawalla said, "Central Government has a lot of stock of Covisheild and also Covovax vaccine will get approval as a booster in the next 10 to 15 days." (Representative Image (Reuters))

3 / 9

The Covovax vaccine is a protein subunit vaccine that is made by isolating a piece of the actual virus. (Representative Image (File Photo))

Published on Jan 09, 2023 03:04 PM IST

The Covovax vaccine is a protein subunit vaccine that is made by isolating a piece of the actual virus. (Representative Image (File Photo))

4 / 9

The Covovax vaccine was approved for restricted use on adults and children last year. (Representative Image (File Photo))

Published on Jan 09, 2023 03:04 PM IST

The Covovax vaccine was approved for restricted use on adults and children last year. (Representative Image (File Photo))

5 / 9

The Covovax vaccine is developed by Novavax and the Coalition for Epidemic Preparedness Innovations (CEPI). (HT File Photo)

Published on Jan 09, 2023 03:04 PM IST

The Covovax vaccine is developed by Novavax and the Coalition for Epidemic Preparedness Innovations (CEPI). (HT File Photo)

6 / 9

This type of vaccine contains part of the coronavirus spike protein which your immune system cells recognise as a threat and begin building an immune response against it. (Representative Image (Reuters))

Published on Jan 09, 2023 03:04 PM IST

This type of vaccine contains part of the coronavirus spike protein which your immune system cells recognise as a threat and begin building an immune response against it. (Representative Image (Reuters))

7 / 9

The Covovax vaccine is administered intramuscularly in two doses. The SII recommends a gap of three weeks between the shots. (Representative Image (Reuters))

Published on Jan 09, 2023 03:04 PM IST

The Covovax vaccine is administered intramuscularly in two doses. The SII recommends a gap of three weeks between the shots. (Representative Image (Reuters))

8 / 9

When asked about the availability of the Covisheild vaccine and its lack of supply to the state and district, Adar Poonawalla said, "The central government has a lot of stock of Covisheild they can give it to the state, as of now production of Covisheild is at a halt at SII, we can start it if needed but the Covovax vaccine will get approval as a booster in the next 10 to 15 days, it works well against the Omicron variant of coronavirus." (Representative Image (AP))

Published on Jan 09, 2023 03:04 PM IST

When asked about the availability of the Covisheild vaccine and its lack of supply to the state and district, Adar Poonawalla said, "The central government has a lot of stock of Covisheild they can give it to the state, as of now production of Covisheild is at a halt at SII, we can start it if needed but the Covovax vaccine will get approval as a booster in the next 10 to 15 days, it works well against the Omicron variant of coronavirus." (Representative Image (AP))

9 / 9

"During Covid-19, everyone was looking at India, not just in terms of healthcare but because the country managed to take care of a huge population and also helped 70 to 80 nations, This was all possible because of the leadership of our central government and state governments, healthcare workers, manufacturers, all of whom worked together with one common goal," he added.(Representative Image (Reuters))

Published on Jan 09, 2023 03:04 PM IST

"During Covid-19, everyone was looking at India, not just in terms of healthcare but because the country managed to take care of a huge population and also helped 70 to 80 nations, This was all possible because of the leadership of our central government and state governments, healthcare workers, manufacturers, all of whom worked together with one common goal," he added.(Representative Image (Reuters))

News / Photos / News / Covovax Vaccine: All you need to know about Covid-19 booster dose

SHARE

Copy

Whatsapp Twitter Facebook Linkedin

© 2024 HindustanTimes

Story Saved

Live Score

Your Subscription Plan

Saved Articles

New Delhi ⁰C

Tuesday, December 03, 2024

Start 14 Days Free Trial Subscribe Now

Follow Us On